Comment on

• Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.

  Méndez-Navarro J, Corey KE, Zheng H, Barlow LL, Jang JY, Lin W, Zhao H, Shao RX, McAfee SL, Chung RT. Méndez-Navarro J, et al. Liver Int. 2011 Mar;31(3):330-9. doi: 10.1111/j.1478-3231.2010.02332.x. Epub 2010 Aug 25. Liver Int. 2011. PMID: 20738779 Free PMC article.
• Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma is not rare in Japanese patients with past hepatitis B virus infection.

  Watanabe M, Shibuya A, Tsunoda Y, Danbara M, Ishii R, Ohsaka M, Takada J, Tanaka Y, Okuwaki Y, Minamino T, Hidaka H, Nakazawa T, Horie R, Higashihara M, Koizumi W. Watanabe M, et al. Liver Int. 2011 Mar;31(3):340-7. doi: 10.1111/j.1478-3231.2010.02417.x. Epub 2010 Dec 7. Liver Int. 2011. PMID: 21134110